Call Us + 33 1 84 88 31 00

Article R5122-3 of the French Public Health Code

When permitted under the provisions of Article L. 5122-6, advertising of a medicinal product to the general public : 1° Is designed in such a way that the advertising nature of the message is obvious and the product is clearly identified as a medicinal product; 2° Contains at least : a) The name of the medicinal product and the common name ; b) Information essential for the proper use of…

Read More »

Article R5122-4 of the French Public Health Code

Without prejudice to the provisions of Article L. 5122-7, advertising of a medicinal product to the general public may not include any element which : 1° Makes medical consultation or surgical intervention appear superfluous, in particular by offering a diagnosis or recommending treatment by mail order; 2° Suggest that the effect of the medicinal product is guaranteed, that it has no adverse effects, or that it is superior or equal…

Read More »

Article R5122-5 of the French Public Health Code

A schedule of periods for submitting the visa applications referred to in Article L. 5122-8 is set for each year, by decision of the Director General of the National Agency for the Safety of Medicines and Health Products published on the Agency’s website, before 1st November of the previous year. This schedule determines at least four periods per year, each lasting between one week and two months, during which applications…

Read More »

Article R5122-6 of the French Public Health Code

When the application is submitted, the applicant assigns an internal reference number to each of the advertising media, in accordance with the rules defined by a decision of the Director General of the Agence nationale de sécurité du médicament et des produits de santé. Advertising distributed to the public must mention this number, except in the case of advertising on a radio broadcasting medium.

Read More »

Article R5122-7 of the French Public Health Code

The withdrawal of the visa provided for in the third paragraph of Article L. 5122-8 is decided by the Director General of the Agence nationale de sécurité du médicament et des produits de santé after the beneficiary of the visa has been invited, by any means which provides proof of the date of receipt of this notice, to present its written or oral observations within a period set by the…

Read More »

Contact a French lawyer now

Contact a French Business Lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.